Preclinical and clinical evidence suggests that ketamine can mitigate psychological benzodiazepine receptor (BZDR) withdrawal symptoms.

Authors

• Person: Not available Organization: Frontiers in Psychiatry
  The Montreal model: an integrative biomedical-psychedelic ...

Sources

• The Montreal model: an integrative biomedical-psychedelic ... www.frontiersin.org Frontiers in Psychiatry via serper

Referenced by nodes (1)

• ketamine concept